METLIFE INC(MET)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #176 of 2,879 stocksTOP 10%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
MET Stock Analysis & AI Quality Score
AI stock analysis and institutional research for METLIFE INC (MET), a Financials sector company. 13F Pro's AI-powered ranking engine scores MET at 73.9/100 on a 32-signal composite quality model, placing it at rank #176 of 2,879 stocks — the top 10% of the AI-ranked universe. MET scores in the top quartile across free cash flow (98.1), profitability (96.9), earnings quality (81.9). Areas of concern include balance sheet strength (39.1), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), METLIFE INC reports quarterly revenue of $19.1B, net income of $1.2B, an operating margin of 8.6%. Top institutional holders of MET by reported 13-F value include BlackRock,, DODGE & COX, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. MET trades on the NYSE exchange and files with the SEC under CIK 1099219. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MET daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for METLIFE INC directly from SEC EDGAR. METLIFE INC's 13F Pro composite quality score has ranged between 44 and 74 since 2021, currently 73.9 — an improving long-term trajectory across 28 quarterly and live scoring snapshots.
What's Driving MET's Business? Latest 10-Q Breakdown
✓ 15/15 datapoints verifiedAI-extracted from METLIFE INC's 10-Q filed 2026-05-07 — Q1 2026 (quarter ended March 31, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
MetLife reported Q1 2026 net income available to common shareholders of $1.1B, up 30% from $879M in Q1 2025, driven by $237M improvement in adjusted earnings and favorable tax rates.
Biggest Revenue Drivers
Total revenue: $19.1B+2.7% YoY
Growth in both voluntary and core products in Group Benefits; strong sales and persistency in Latin America
Higher returns on private equity funds; higher yields on fixed income securities; higher average invested assets
Higher fee income from Japan's yen-denominated and foreign currency annuity products
Foreign currency losses in current period vs. gains prior period; higher real estate impairments
Largest Expense Items
Unfavorable morbidity in Group Benefits offset by favorable mortality results
Higher average interest crediting rates on investment-type products in Asia
Higher commissions, direct and employee-related expenses; higher other segment expenses
Margins: Operating margins improved modestly despite revenue growth, driven by volume gains and favorable underwriting in Group Benefits and Asia. The company maintained disciplined expense management, though higher interest crediting rates in Asia offset some benefit from revenue growth.
Watch Items from the Filing
- Asia segment showed strong adjusted earnings growth of $115M (+31% YoY) driven by market factors and volume growth, but higher interest crediting rates on investment products remain a headwind to margins.
- Latin America adjusted premiums, fees and other revenues surged 25% YoY on reported basis, but only 11% on constant currency basis, indicating significant foreign exchange tailwind that may reverse if currencies weaken.
- Net investment gains deteriorated $283M YoY due to foreign currency losses and higher real estate impairments ($136M in Q1 2026 vs. $1M in Q1 2025), signaling potential pressure from real estate portfolio.
- Corporate & Other adjusted earnings available to common shareholders declined $48M YoY, including $33M headwind from reinsurance transactions closed in December 2025, reducing near-term earnings visibility.
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.
Revenue
Q1 2026
$19.1B
Net Income
Q1 2026
$1.2B
Free Cash Flow
Q1 2026
$2.7B
Operating Margin
Q1 2026
8.6%
ROIC
Q1 2026
6.0%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+8.6% YoYNet Income
-20.0% YoYOperating Income
+2.4% YoYEPS (Diluted)
-20.7% YoYTotal Assets
+10.0% YoYTotal Debt
-23.7% YoYOp. Cash Flow
+17.1% YoY| Metric | FY 2025 | FY 2024 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
| Revenue | $77.08B +8.6% | $70.99B +3.2% | $68.77B +0.1% | $68.70B -1.3% | $69.62B +2.5% | $67.94B |
| Net Income | $3.38B -20.0% | $4.23B +79.5% | $2.35B -65.7% | $6.86B +16.2% | $5.90B +15.1% | $5.12B |
| Operating Income | $6.14B +2.4% | $6.00B +0.3% | $5.98B | — | — | — |
| EPS (Diluted) | $4.71 -20.7% | $5.94 -5.7% | $6.30 -17.6% | $7.65 +26.2% | $6.06 +23.4% | $4.91 |
| Total Assets | $745.17B +10.0% | $677.46B +2.2% | $663.07B -12.7% | $759.71B +2.6% | $740.46B +7.7% | $687.54B |
| Total Debt | $355.0M -23.7% | $465.0M +165.7% | $175.0M -48.7% | $341.0M +45.1% | $235.0M -12.3% | $268.0M |
| Operating Cash Flow | $17.09B +17.1% | $14.60B +11.9% | $13.04B +5.6% | $12.35B -10.4% | $13.79B +17.4% | $11.74B |
AI Insight: MET Financial Trends
MetLife's revenue surged 28% in Q4 2025 to $23.8B while maintaining stable debt levels below $400M.
• Revenue jumped from $17.4B in Q3 2025 to $23.8B in Q4 2025, a 37% quarterly increase.
• Total debt declined from $465M in Q4 2024 to $355M in Q4 2025, down 24%.
• Operating cash flow strengthened to $7.1B in Q4 2025 versus $4.6B in Q4 2024.
⚠ Net income dropped 36% from Q4 2024's $1.3B to $809M in Q4 2025 despite revenue surge.
⚠ Revenue volatility evident with Q4 2025 spike contrasting prior quarters' $17-18B range.
AI Insight: MET Ratio Trends
MetLife's operating margin improved from 6.5% in Q1 2024 to 8.0% in Q2 2025, but profitability declined in Q4 2025 with net margin falling to 3.4%.
• Operating margin expanded from 6.5% in Q1 2024 to 8.0% in Q2 2025, showing gradual improvement.
• ROIC strengthened from 14.6% in Q1 2024 to 23.4% in Q4 2025, indicating improving capital efficiency.
• Debt-to-equity ratio remained extremely low at 0.01 throughout the period, maintaining strong balance sheet.
⚠ Net margin declined sharply from 5.2% in Q3 2025 to 3.4% in Q4 2025.
⚠ ROE fell from 18.5% in Q4 2024 to 11.4% in Q4 2025, reversing prior gains.
Get alerted when MET's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for METLIFE INC including:
Top Institutional Holders of MET
BlackRock, Inc.
$3.6B51,423,880 shDODGE & COX
$3.6B51,114,776 shVANGUARD CAPITAL MANAGEMENT LLC
$2.5B35,856,817 shVANGUARD PORTFOLIO MANAGEMENT LLC
$2.2B30,813,441 shSTATE STREET CORP
$1.8B25,220,389 shGEODE CAPITAL MANAGEMENT, LLC
$941.9M13,244,276 shPZENA INVESTMENT MANAGEMENT LLC
$799.4M11,303,819 shMORGAN STANLEY
$786.5M11,120,757 shDIMENSIONAL FUND ADVISORS LP
$503.6M7,123,164 shInvesco Ltd.
$489.3M6,919,363 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $3.6B | 51,423,880 |
| DODGE & COX | $3.6B | 51,114,776 |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.5B | 35,856,817 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.2B | 30,813,441 |
| STATE STREET CORP | $1.8B | 25,220,389 |
| GEODE CAPITAL MANAGEMENT, LLC | $941.9M | 13,244,276 |
| PZENA INVESTMENT MANAGEMENT LLC | $799.4M | 11,303,819 |
| MORGAN STANLEY | $786.5M | 11,120,757 |
| DIMENSIONAL FUND ADVISORS LP | $503.6M | 7,123,164 |
| Invesco Ltd. | $489.3M | 6,919,363 |
More Financials Companies
View all Financials →Put MET on your watchlist
Track score changes the day METLIFE INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is MET a good stock to buy?
13F Pro's AI-powered analysis of METLIFE INC (MET) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Financials sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for MET are available on the MET stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own MET?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling MET. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of METLIFE INC's investment landscape.